Thyroid medications during pregnancy

Therapeutic Drug Monitoring

Volumn 28, Issue 3, 2006, Pages 431-441

  Bach Huynh, Thien Giang ^a   Jonklaas, Jacqueline ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Diagnosis; Hyperthyroidism; Hypothyroidism; Pregnancy; Therapy

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CONTRAST MEDIUM; IODIDE; IODINE; IODINE 131; IOPANOIC ACID; IOPODIC ACID; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIOTHYRONINE SODIUM; MULTIVITAMIN; PERCHLORATE; POTASSIUM PERCHLORATE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROID HORMONE; THYROXINE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; BIOEQUIVALENCE; BRADYCARDIA; CONCEPTION; DATA ANALYSIS; DIET SUPPLEMENTATION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SAFETY; EMBRYOPATHY; EUTHYROIDISM; FEMALE; FETUS (ANATOMY); FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; GOITER; GRAVES DISEASE; GROWTH RETARDATION; HUMAN; HYPERTELORISM; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; MICROGNATHIA; MUSCLE HYPOTONIA; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; NEUROTOXICITY; NYSTAGMUS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SECOND TRIMESTER PREGNANCY; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID GLAND; THYROIDECTOMY; THYROIDITIS;

ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE; IODINE RADIOISOTOPES; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROXINE; TRACE ELEMENTS; VITAMINS;

EID: 33748172822     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000211834.41844.82     Document Type: Review

References (134)

1. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid. 1999;9:631-635.
2. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med. 1994;331:1072-1078.
3. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18:404-433.
4. Glinoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71:276-287.
5. Katz FH, Kappas A. The effects of estradiol and estriol on plasma levels of cortisol and thyroid hormone-binding globulins and on aldosterone and cortisol secretion rates in man. J Clin Invest. 1967;46:1768-1777.
6. Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65:689-696.
7. DeGroot LJ, Larsen, PR, Hennemann G. Thyroid Dysfunction in the Pregnant Patient. 6 ed. New York: Churchill Livingstone Inc; 1996. [The thyroid and its diseases].
8. Fisher DA, Polk DH, Wu SY. Fetal thyroid metabolism: a pluralistic system. Thyroid. 1994;4:367-371.
9. Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13-16.
10. Glinoer D. Pregnancy and iodine. Thyroid. 2001;11:471-481.
11. Fernandez-Soto ML, Jovanovic LG, Gonzalez-Jimenez A, et al. Thyroid function during pregnancy and the postpartum period: iodine metabolism and disease states. Endocr Pract. 1998;4:97-105.
12. Glinoer D. The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract Res Clin Endocrinol Metab. 2004;18:133-152.
13. Glinoer D, De Nayer P, Robyn C, et al. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest. 1993;16:881-888.
14. Dashe JS, Casey BM, Wells CE, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol. 2005;106:753-757.
15. Price A, Davies R, Heller SR, et al. Asian women are at increased risk of gestational thyrotoxicosis. J Clin Endocrinol Metab. 1996;81:1160-1163.
16. Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat Endocrinol. 2005;4:31-41.
17. Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev. 1993;14:194-202.
18. Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid. 2005;15:1035-1039.
19. Price A, Obel O, Cresswell J, et al. Comparison of thyroid function in pregnant and non-pregnant Asian and Western Caucasian women. Clin Chim Acta. 2001;308:91-98.
20. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
21. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem. 2001;38:329-332.
22. Glinoer D, Riahi M, Grun JP, et al. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab. 1994;79:197-204.
23. Ball R, Freedman DB, Holmes JC, et al. Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact, not technical artefact. Clin Chem. 1989;35:1891-1896.
24. Soldin OP, Tractenberg RE, Hollowell JG, et al. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid. 2004;14:1084-1090.
25. Weeke J, Dybkjaer L, Granlie K, et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh). 1982;101:531-537.
26. Price A, Griffiths H, Morris BW. A longitudinal study of thyroid function in pregnancy. Clin Chem. 1989;35:275-278.
27. Soldin SJ, Soukhova N, Janicic N, et al. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta. 2005;358:113-118.
28. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid. 2005;15:44-53.
29. Roti E, Gardini E, Minelli R, et al. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J Endocrinol Invest. 1991;14:1-9.
30. d'Herbomez M, Forzy G, Gasser F, et al. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med. 2003;41:942-947.
31. Sapin R, D'Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab. 2004;50:581-584.
32. Wang R, Nelson JC, Weiss RM, et al. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid. 2000;10:31-39.
33. Elnagar B, Eltom A, Wide L, et al. Iodine status, thyroid function and pregnancy: study of Swedish and Sudanese women. Eur J Clin Nutr. 1998;52:351-355.
34. Whitworth AS, Midgley JE, Wilkins TA. A comparison of free T4 and the ratio of total T4 to T4-binding globulin in serum through pregnancy. Clin Endocrinol (Oxf). 1982;17:307-313.
35. Ballabio M, Poshychinda M, Ekins RP. Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab. 1991;73:824-831.
36. Nissim M, Giorda G, Ballabio M, et al. Maternal thyroid function in early and late pregnancy. Horm Res. 1991;36:196-202.
37. Berghout A, Endert E, Ross A, et al. Thyroid function and thyroid size in normal pregnant women living in an iodine replete area. Clin Endocrinol (Oxf). 1994;41:375-379.
38. Liberman CS, Pino SC, Fang SL, et al. Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab. 1998;83:3545-3549.
39. Kung AW, Lao TT, Chau MT, et al. Goitrogenesis during pregnancy and neonatal hypothyroxinaemia in a borderline iodine sufficient area. Clin Endocrinol (Oxf). 2000;53:725-731.
40. Soukhova N, Soldin OP, Soldin SJ. Isotope dilution tandem mass spectrometric method for T4/T3. Clin Chim Acta. 2004;343:185-190.
41. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-555.
42. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab. 2000;85:3975-3987.
43. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf). 1999;50:149-155.
44. Smyth PP. Variation in iodine handling during normal pregnancy. Thyroid. 1999;9:637-642.
45. Glinoer D, De Nayer P, Delange F, et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab. 1995;80:258-269.
46. Pedersen KM, Laurberg P, Iversen E, et al. Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. J Clin Endocrinol Metab. 1993;77:1078-1083.
47. Nohr SB, Jorgensen A, Pedersen KM, et al. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab. 2000;85:3191-3198.
48. Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid. 2000;10:871-887.
49. Vitti P, Aghini Lombardi F, Antonangeli L, et al. Mild iodine deficiency in fetal/neonatal life and neuropsychological performances. Acta Med Austriaca. 1992;19(Suppl 1):57-59.
50. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab. 1998;83:3401-3408.
51. Indicators for assessing iodine deficiency disorders and their control through salt iodinization, Document WHO/NUT. 6:36;1994. (WHO/UNICEF/ICCIDD), ed.
52. National Center for Health Statistics, http://www.cdc.gov/nchs/products/ pubs/pubd/hestats/iodine.htm, last accessed 5/30/05.
53. Soldin OP, Soldin SJ, Pezzullo JC. Urinary iodine percentile ranges in the United States. Clin Chim Acta. 2003;328:185-190.
54. Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health And Nutrition Examination Survey 2001-2002. Thyroid. 2005;15:692-699.
55. Pearce EN, Pino S, He X, et al. Sources of dietary iodine: bread, cows' milk, and infant formula in the Boston area. J Clin Endocrinol Metab. 2004;89:3421-3424.
56. Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes. Washington, DC: National Academy Press; 2001.
57. www.drugstore.com; www.cvs.com; www.walgreens.com; www.riteaid.com; www.PromisePrenatal.com, last accessed 5/22/05.
58. Smallridge RC, Glinoer D, Hollowell JG, et al. Thyroid function inside and outside of pregnancy: what do we know and what don't we know? Thyroid. 2005;15:54-59.
59. Soldin OP, Tractenberg RE, Pezzullo JC. Do thyroxine and thyroid-stimulating hormone levels reflect urinary iodine concentrations? Ther Drug Monit. 2005;27:178-185.
60. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol. 2005;58:449-452.
61. Lazarus JH. Epidemiology and prevention of thyroid disease in pregnancy. Thyroid. 2002;12:861-865.
62. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res. 2003;13(Suppl A):S45-S54.
63. Smallridge RC, Ladenson PW. Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab. 2001;86:2349-2353.
64. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127-130.
65. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239-245.
66. Wiersinga WM. Thyroid hormone replacement therapy. Horm Res. 2001;56(Suppl 1):74-81.
67. Clyde PW, Harari AE, Getka EJ, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290:2952-2958.
68. Siegmund W, Spieker K, Weike AI, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf). 2004;60:750-757.
69. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, et al. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142:412-424.
70. Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88:4543-4550.
71. Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003;88:4551-4555.
72. Wartofsky L. Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid. 2004;14:247-248.
73. Cooper DS. Combined T4 and T3 therapy - back to the drawing board. JAMA. 2003;290:3002-3004.
74. Chopra IJ, Baber K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Metabolism. 2003;52:122-128.
75. Electronic Orange Book, http://www.fda.gov/cder/ob/default.htm, last accessed 5/30/05.
76. Generic levothyroxine. Med Lett Drugs Ther. 2004;46:77-78.
77. Docket Number 97N-0314, Prescription Drug Products; Levothyroxine Sodium. 62 Federal Register 43535-43538, 1997.
78. Hennessey JV, Burman KD, Wartofsky L. The equivalency of two L-thyroxine preparations. Ann Intern Med. 1985;102:770-773.
79. US FDA Dockets Management (Levothyroxine Sodium Therapeutic Equivalence), http://www.fda.gov/ohrms/dockets/dockets/05n0137/05n-0137.htm, last accessed 5/30/05.
80. Carr D, McLeod DT, Parry G, et al. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf). 1988;28:325-333.
81. Blakesley V, Awni W, Locke C, et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid. 2004;14:191-200.
82. Hennessey JV. Levothyroxine a new drug? Since when? How could that be? Thyroid. 2003;13:279-282.
83. Stockigt J. Testing the bioavailability of oral L-thyroxine by studying its absorption: smoke or mirrors? Thyroid. 2004;14:167-168.
84. Toft A. Which thyroxine? Thyroid. 2005;15:124-126.
85. Mayor GH, Orlando T, Kurtz NM. Limitations of levothyroxine bioequivalence evaluation: analysis of an attempted study. Am J Ther. 1995;2:417-432.
86. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2000 Guidance for Industry: Levothyroxine Sodium Tablets-In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing.
87. Drugs @ FDA, http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index. cfm, last accessed 5/30/05.
88. Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium (see also http://www.thyroid. org/professionals/advocacy/04_12_08_thyroxine.html). Thyroid. 2004;14:486.
89. Wartofsky L. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Expert Opin Pharmacother. 2002;3:727-732.
90. Mandel SJ, Larsen PR, Seely EW, et al. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91-96.
91. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249.
92. Girling JC, de Swiet M. Thyroxine dosage during pregnancy in women with primary hypothyroidism. Br J Obstet Gynaecol. 1992;99:368-370.
93. Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160:63-70.
94. Anselmo J, Cao D, Karrison T, et al. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004;292:691-695.
95. Masiukiewicz US, Burrow GN. Hyperthyroidism in pregnancy: diagnosis and treatment. Thyroid. 1999;9:647-652.
96. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab. 2004;18:267-288.
97. Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol. 2004;44:191-196.
98. Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 1986;315:24-28.
99. Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1997;82:3633-3636.
100. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am. 1998;27:127-149.
101. Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 1999;83:43-46.
102. Fontanilla JC, Schneider AB, Sarne DH. The use of oral radiographic contrast agents in the management of hyperthyroidism. Thyroid. 2001;11:561-567.
103. Braga M, Cooper DS. Clinical review 129: oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab. 2001;86:1853-1860.
104. Chopra IJ, van Herle AJ, Korenman SG, et al. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab. 1995;80:2178-2180.
105. Brown RS, Cohen JH III, Braverman LE. Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid. J Pediatr. 1998;132:903-905.
106. Davison S, Lennard TW, Davison J, et al. Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester. Clin Endocrinol (Oxf). 2001;54:559-561.
107. Baeza A, Aguayo J, Barria M, et al. Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol (Oxf). 1991;35:439-442.
108. Karpman BA, Rapoport B, Filetti S, et al. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. J Clin Endocrinol Metab. 1987;64:119-123.
109. Atkins P, Cohen SB, Phillips BJ. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus. Drug Safety. 2000;23:229-244.
110. Carswell F, Kerr MM, Hutchison JH. Congenital goitre and hypothyroidism produced by maternal ingestion of iodides. Lancet. 1970;1:1241-1243.
111. Senior B, Chernoff HL. Iodide goiter in the newborn. Pediatrics. 1971;47:510-515.
112. Momotani N, Hisaoka T, Noh J, et al. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab. 1992;75:738-744.
113. Lomenick JP, Jackson WA, Backeljauw PF. Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. J Perinatol. 2004;24:397-399.
114. Seminara SB, Daniels GH. Amiodarone and the thyroid. Endocr Pract. 1998;4:48-57.
115. Magee LA, Downar E, Sermer M, et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol. 1995;172:1307-1311.
116. Plomp TA, Vulsma T, de Vijlder JJ. Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;43:201-207.
117. Grosso S, Berardi R, Cioni M, et al. Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. J Endocrinol Invest. 1998;21:699-702.
118. Bartalena L, Bogazzi F, Braverman LE, et al. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001;24:116-130.
119. Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab. 1996;81:2930-2933.
120. Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev. 1998;50:89-105.
121. Soldin OP, Braverman LE, Lamm SH. Perchlorate clinical pharmacology and human health: a review. Ther Drug Monit. 2001;23:316-331.
122. Boger MS, Perrier ND. Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin North Am. 2004;84:849-874.
123. Roti E, Minelli R, Gardini E, et al. Controversies in the treatment of thyrotoxicosis. Adv Endocrinol Metab. 1994;5:429-460.
124. Pekonen F, Lamberg BA. Thyrotoxicosis during pregnancy. Ann Chir Gynaecol. 1978;67:165-173.
125. Ghaneim A, Atkins P. Management of thyrotoxicosis in pregnancy. Int J Clin Pract. 1998;52:36-38.
126. Stabin MG, Watson EE, Marcus CS, et al. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism. J Nucl Med. 1991;32:808-813.
127. Gorman CA. Radioiodine and pregnancy. Thyroid. 1999;9:721-726.
128. Chow SM, Yau S, Lee SH, et al. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys. 2004;59:992-1000.
129. Berg GE, Nystrom EH, Jacobsson L, et al. Radioiodine treatment of hyperthyroidism in a pregnant women. J Nucl Med. 1998;39:357-361.
130. Stoffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med. 1976;17:146-149.
131. Calderwood C, Williams H, Campbell IW, et al. Cordocentesis to predict fetal outcome after administration of radio-active iodine for Graves' disease. J Obstet Gynaecol. 2002;22:217-218.
132. Lin JD, Wang HS, Weng HF, et al. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas. J Endocrinol Invest. 1998;21:662-667.
133. Ayala C, Navarro E, Rodriguez JR, et al. Conception after iodine-131 therapy for differentiated thyroid cancer. Thyroid. 1998;8:1009-1011.
134. Schlumberger M, De Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med. 1996;37:606-612.